Related Articles
RBM15‑mediating MDR1 mRNA m<sup>6</sup>A methylation regulated by the TGF‑β signaling pathway in paclitaxel‑resistant ovarian cancer
Effects and mechanism of RhoC downregulation in suppressing ovarian cancer stem cell proliferation, drug resistance, invasion and metastasis
CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro
microRNA‑106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells
hMSH2 expression is associated with paclitaxel resistance in ovarian carcinoma, and inhibition of hMSH2 expression in vitro restores paclitaxel sensitivity